Futura Medical Share News (FUM)

Futura Medical Information

Buy FUM Shares
Add FUM to Watchlist
Add FUM to Alert

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 40.00

Bid: 39.40

Ask: 40.00

Change: -1.60 (-3.87%)

Spread: 0.60 (1.523%)

Open: 41.30

High: 41.30

Low: 39.55

Prev. Close: 41.30

Last checked at -

Futura Says Licensing Of Erectile Dysfunction Gel Remains Top Priority

Wed, 13th Jun 2018 12:36

LONDON (Alliance News) - Futura Medical PLC Chairman John Clarke said Wednesday the company continues to make "good progress" both in product development and commercialisation.

In his annual general meeting statement, Clarke added that the Surrey-based healthcare company expects to start phase III of its MED2002 clinical study in September.

MED2002 is the company's gel for the treatment of erectile dysfunction, about which Futura is in advanced discussions with potential commercial partners.

"Completion of a significant out-licensing agreement for MED2002 remains a top priority for the company and, whilst negotiations proceed, we will continue to maintain the momentum in the product's development," Clarke added.

Furthermore, the company's condom CSD500 received regulatory approval in Kuwait, where it will be launched "as soon as practicable", Clarke added.

Futura Medical shares were trading 4.1% lower at 33.10 pence each.

More News

2 Mar 2010 12:38

Small caps round-up: Share, Jetion Solar, Futura Medical...

Share, parent company of retail stockbroker The Share Centre, lifted profits last year to £2.35m from £1.46m on turnover of £14.1m, up from £12m. There was a significant increase in retail investor activity - especially online with deal volumes up by 75% on 2008, Share said. The interim dividend is

16 Dec 2009 08:43

Futura a step closer to TPR100 deal

Consumer healthcare product developer Futura Medical is in talks with a major pharmaceutical company on a licensing deal for its pain relief product, TPR100. The company interested in licensing TPR100 is the same one with which Futura announced an evaluation agreement in July 2009. Futura has rece

12 Nov 2009 14:32

Small caps round-up: Syntopix, Atlantic Coal, Brady...

Drug developer Syntopix shares rallied as it reported positive phase 2 results for its lead dermatological compound SYN0126, for the treatment of acneic skin. Following the results, Syntopix has decided to focus its development efforts around three specific core compounds: SYN0126, SYN1113 and SYN

10 Nov 2009 09:22

Production changes in line for Futura condom

Futura Medical said a number of potential improvements to the production process of its ‘erectogenic’ condom have been identified by Durex condom maker SSL International. The proposed changes to the manufacturing process at SSL’s manufacturing facility in India have the potential to improve product

23 Sep 2009 13:10

Small caps round-up: Lifeline Scientific, Autologic, Bond...

The market liked Lifeline Scientific's maiden interim operating profit of $73,000 versus last year's loss of $3.1m, as the sale of 11 new LifePort kidney transporters helped revenue jump 123% to $7.75m. 'Trading was in-line with management's expectations during the first half and the board is confi

20 Jul 2009 08:35

Small caps round-up: Abbeycrest, Synchronica, Futura...

Jewellery maker Abbeycrest said it is performing in line with expectations as it undergoes a turnaround plan. The unbranded jewellery business is delivering much improved results on a significantly reduced turnover, the firm said. The brands division is making good progress with its higher margin b

10 Jun 2009 08:27

Small caps round-up: Intelligent Environments, LPA Group, Mobile Streams...

Banking software firm Intelligent Environments said trading in the current year to date has been robust. The group said it has experienced strong demand from new and existing customers to launch platforms to attract and retain retail deposits online. "Our strategy to develop a long term recurring r

13 May 2009 09:20

Small caps round-up: H&T Group, China Medical, Fyffes...

Pawnbroker H&T Group said it has traded "significantly" ahead of expectations for the year to date. It also said it was positive about prospects for the current year but remains conscious of the current difficult economic climate. "The principal reason for the strong performance is the sustained go

Latest Share Chat

Futura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Futura Says Licensing Of Erectile Dysfunction Gel Remains Top Priority

Login to your account

Quickpicks are a member only feature

Login to your account